Category Archives: Opioid access

Project Estar ao Seu Lado: Living with total pain in Brazil

In this special post to celebrate World Hospice and Palliative Care Day tomorrow, Santiago Rodríguez Corrêa, a family physician, and Carla Mazuko, a nurse, from Project Estar ao Seu Lado, Brazil, pick up the theme of this year’s event: ‘Living … Continue reading

Posted in ADVOCACY & POLICY, Opioid access | Tagged , | 2 Comments

Living and dying in pain: It doesn’t have to happen

  World Hospice and Palliative Care Day is a unified day of action to celebrate and support hospice and palliative care around the world. Ahead of this year’s event on 8 October, Dr Stephen R Connor, Executive Director, Worldwide Hospice … Continue reading

Posted in ADVOCACY & POLICY, Opioid access | Tagged | Leave a comment

Opioid overdose death epidemic sensationalised at the cost of pain patients

Willem Scholten, PharmD MPA, Consultant – Medicines and Controlled Substances, Willem Scholten Consultancy, Lopik, the Netherlands Recently, I published an article with Jack E. Henningfield on the ‘opioid overdose death epidemic’ in which we challenged the usual view of an epidemic … Continue reading

Posted in ADVOCACY & POLICY, Opioid access | Tagged | 4 Comments

New INCB supplement on controlled medicines – a great tool for advocacy

Dr Katherine Irene Pettus, PhD, Advocacy Officer, International Association for Hospice and Palliative Care, explains the background to a new report published in Vienna on 3 February 2016 to improve access to controlled medicines. The International Narcotics Control Board (INCB) … Continue reading

Posted in ADVOCACY & POLICY, Opioid access | Tagged | 6 Comments

European Association for Palliative Care and the Civil Society Forum on Drugs

The EAPC has recently been involved in discussions within the European Union (EU) in preparation for the upcoming United Nations General Assembly Special Session on the World Drug Problem (UNGASS). Dr David Oliver, Board member of the European Association for … Continue reading

Posted in ADVOCACY & POLICY, EAPC Board Members, Opioid access | Tagged , , | 1 Comment

Misuse of low-quality data for drawing conclusions on opioid dependence is a health abuse

Willem Scholten, PharmD MPA, Consultant – Medicines and Controlled Substances, Willem Scholten Consultancy, Lopik, the Netherlands; Jack E. Henningfield, PhD, Vice-President, Research and Health Policy, Pinney Associates, Bethesda, Maryland, and The Johns Hopkins University School of Medicine, Baltimore, Maryland, United States. … Continue reading

Posted in ADVOCACY & POLICY, Opioid access | Tagged | Leave a comment

Strengthening our understanding of ‘Access to Opioid Medication in Europe’ (ATOME): Highlights of results and achievements

Eugenia Larjow, sociologist at the University Hospital of Bonn, Germany on behalf of the ATOME Consortium. The ATOME project comes to a close after five years of research and advocacy. The results strengthen our knowledge of barriers and challenges to … Continue reading

Posted in ADVOCACY & POLICY, ATOME, Opioid access | Leave a comment